Ingevity Corporation reported its financial results for the second quarter of 2025, showing a 7% decline in net sales to $365.1 million, primarily due to reduced sales in the Performance Chemicals segment. The company experienced a net loss of $146.5 million, largely impacted by a pre-tax non-cash goodwill impairment charge of $183.8 million related to the Advanced Polymer Technologies segment. This charge was attributed to heightened global trade uncertainty and its effect on industrial demand recovery forecasts. Adjusted earnings increased 39% to $51.1 million, while adjusted EBITDA rose by 9% to $110.0 million, with the EBITDA margin improving to 30.1%. These improvements were mainly due to successful repositioning actions in the Performance Chemicals segment, which led to reduced raw material costs and a better product mix. Ingevity has updated its guidance, raising the low-end of its adjusted EBITDA forecast to between $390 million and $415 million, reflecting solid results and improved expectations for North American auto production. The company maintains its full-year sales guidance of between $1.25 billion and $1.40 billion.